FTC clears Omnicom's acquisition of Interpublic with consent order

The U.S. Federal Trade Commission has cleared a major antitrust hurdle for Omnicom Group's proposed $13.5 billion acquisition of Interpublic Group, granting early termination of the Hart-Scott-Rodino waiting period via a consent order. This order, which addresses concerns about political viewpoint-based advertising placement and is subject to a 30-day public comment period, advances the merger of two leading advertising holding companies, expected to close in H2 2025 pending other regulatory approvals. Interpublic Group also recently reported stronger-than-expected Q1 2025 earnings, with EPS and revenue surpassing forecasts, providing a positive financial backdrop amidst the ongoing merger process and strategic restructuring initiatives.

Analysis

The proposed $13.5 billion acquisition of Interpublic Group (IPG) by Omnicom Group (OMC) has cleared a significant U.S. regulatory hurdle with the Federal Trade Commission granting an early termination of the Hart-Scott-Rodino waiting period. This development substantially de-risks the transaction from an antitrust perspective, moving the deal closer to its expected close in the second half of 2025. The approval is contingent on a consent order, which addresses concerns over advertising placements based on political viewpoints and is now subject to a 30-day public comment period. This regulatory progress is complemented by IPG's strong recent financial performance. The company surpassed Q1 2025 expectations with an adjusted EPS of $0.33 against a $0.2697 forecast and revenue of $2 billion, slightly ahead of the $1.99 billion consensus. However, this positive earnings report is tempered by the company's cautious full-year guidance, which projects an organic revenue decrease of 1-2%, alongside a robust adjusted EBITDA margin target of 16.6%, signaling a focus on profitability amidst challenging market conditions and ongoing restructuring efforts.

Key Decisions for Investors

• The FTC's clearance is a major de-risking event for the merger, likely narrowing the arbitrage spread; investors should now shift focus to the remaining international regulatory approvals and the final terms of the consent order.
• Despite IPG's strong Q1 2025 earnings beat, the guidance for a full-year organic revenue decline of 1-2% warrants caution, indicating that underlying industry headwinds persist even as the company executes well on profitability.
• For investors with a long-term horizon in OMC or IPG, the key consideration is the potential for post-merger synergies versus integration risks and any operational limitations imposed by the FTC's consent order.